Have a personal or library account? Click to login
Genetic and reproductive toxicity of lamivudine, tenofovir disoproxil fumarate, efavirenz and their combination in the bone marrow and testicular cells of male mice Cover

Genetic and reproductive toxicity of lamivudine, tenofovir disoproxil fumarate, efavirenz and their combination in the bone marrow and testicular cells of male mice

Open Access
|Jul 2020

References

  1. Aceti, A., Gianserra, L., Lambiase, L., Pennica, A., and Teti, E. (2015). Pharmacogenetics as a tool to tailor antiretroviral therapy: a review, World Journal of Virology, 4(3); 198-208.10.5501/wjv.v4.i3.198453481226279982
  2. AIDS info. FDA-approved HIV medicines. Retrieved March 21, 2017, from https://aidsinfo.nih.gov/education-materials/fact-sheets/21/58/fda-approved-hiv-medicines.
  3. Alabi, O. A., and Bakare, A. A. (2011). Genotoxicity and mutagenicity of electronic waste leachates using animal bioassays, Toxicological and Environmental Chemistry, 93(5); 1073-1088.10.1080/02772248.2011.561949
  4. Alabi, O. A., Silva, A. H., Purnhagen, L. R. P., Gabriela, G. R. A., Leonidas, L. J. M., Fabiola, F. B., Dalmina, M., Pittella, F., Bakare, A. A., and Creczynski-Pasa, T. B. (2019). Genetic, reproductive and oxidative damage in mice triggered by co-exposure of nanoparticles: From a hypothetical scenario to a real concern, Science of The Total Environment, 660; 1264 – 1273.10.1016/j.scitotenv.2019.01.03630743921
  5. Anderson, P. L., and Rower, J. E. (2010). Zidovudine and lamivudine for HIV infection, Clinical Medicine Reviews in Therapeutics, 2; a2004-a2023.10.4137/CMRT.S4557
  6. Andrea, S., Isaacson, I., McGowan, A., Cheng, R., Schooley, T., and Miller, M.D. (2011). Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF, AIDS, 16; 1227–123.10.1097/00002030-200206140-0000412045487
  7. Azu, O. O. (2012). Highly active antiretroviral therapy (HAART) and testicular morphology: current status and a case for a stereologic approach, Journal of Andrology, 33(6); 1130-1142.10.2164/jandrol.112.01675822700761
  8. Bakare, A. A., Mosuro, A. A., and Osibanjo, O. (2005). An in vivo evaluation of induction of abnormal sperm morphology in mice by landfill leachates, Mutation Research, 582(1-2); 28–34.10.1016/j.mrgentox.2004.12.00715781207
  9. Bakare, A. A., Udoakang, A. J., Anifowoshe, A. T., Fadoju, O. M., Ogunsuyi, O. I., Alabi, O. A., Alimba, C. G., and Oyeyemi, I. T. (2016). Genotoxicity of titanium dioxide nanoparticles using the mouse bone marrow micronucleus and sperm morphology assays, Journal of Pollution Effect and Control, 4; 156.
  10. Bartke, A. J., Weir, A., Mathison, P., Roberson, C., and Dalterio, S. (1974). Testicular function in mouse strains with different age of sexual maturation, Journal of Heredity, 65; 204-208.10.1093/oxfordjournals.jhered.a1085044471635
  11. Bayram, S., and Topaktaş, M. (2008). Confirmation of the chromosome damaging effects of lamivudine in in vitro human peripheral blood lymphocytes, Environmental and Molecular Mutagenesis, 49; 328-333.10.1002/em.2039318366100
  12. Broder, S. (2010). The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic, Antiviral Research, 85; 1-18.10.1016/j.antiviral.2009.10.002281514920018391
  13. Bruce, W., and Heddle, J. (1979). The mutagenicity of 61 agents as determined by the micronucleus, Salmonella and sperm abnormality assays, Canadian Journal of Cytology and Genetics, 21; 319-334.10.1139/g79-036
  14. Bruce, W. R., Furrer, R., and Wyrobek, A. J. (1974). Abnormalities in the shape of murine sperm after acute testicular x-irradiation, Mutation Research, 23; 381-386.10.1016/0027-5107(74)90112-2
  15. Calmy, A., Hirschel, B., Cooper, D. A. and Carr, A. (2009). A new era of antiretroviral drug toxicity, Antiviral Therapy, 14; 165-179.10.1177/135965350901400203
  16. Carpenter, C., Fischi, M., and Hammer, S. (1997). Antiretroviral therapy for HIV infection: updated recommendations of the international AIDS society-USA panel, JAMA, 227(24); 1962-1969.10.1001/jama.277.24.1962
  17. Chou, T. C. (2010). Drug combination studies and their synergy quantification using the Chou-Talalay method, Cancer Research, 70(2); 440-446.10.1158/0008-5472.CAN-09-194720068163
  18. Council for International Organization of Medical Sciences (CIOMS). (2012). International guiding principles for biomedical research involving animals. pp1-4.
  19. Creasy, D. M. (2002). Histopathology of the male reproductive system II: Interpretation, Current Protocols in Toxicology, 16; 4.10.1002/0471140856.tx1604s1320963756
  20. de Moraes Filho, A. V., Carvalho, C. J. S., Carneiro, C. C., Vale, C. Rd., Lima, D. C. S., Carvalho, W. F., Viera, T. B., Silva, D. M., Cunha, K. S., and Chen-Chen, L. (2016). Genotoxic and Cytotoxic Effects of antiretroviral combinations in mice bone marrow, PLoS ONE, 11(11): e0165706.10.1371/journal.pone.0165706509183827806085
  21. de Moraes Filho, A. V., Carvalho, C. J. S., Verçosa, C. J., Gonçalves, M. W., Rohde, C., Silva, D. Me.,Cunha, K. S., and Chen-Chen, L. (2017). In vivo genotoxicity evaluation of efavirenz (EFV) and tenofovir disoproxil fumarate (TDF) alone and in their clinical combinations in Drosophila melanogaster, Mutation Research in Genetic Toxicology and Environmental Mutagenesis, 820; 31-38.10.1016/j.mrgentox.2017.05.01228676264
  22. de Oliveira, H. M., Damiani, A. P., Dias, R.D.O., Romão, P. R. T., and Andrade, V. M. (2014). Effect of antiretroviral drugs on DNA damage in mice, Environmental Toxicology and Pharmacology, 37; 390-395.10.1016/j.etap.2013.12.01124441026
  23. Dobrzynska, M., Gajowik, A., Radzikowska, J., Lankoff, A., and Dusinska, M. (2014). Genotoxicity of silver and titanium dioxide nanoparticles in bone marrow cells of rats in vivo, Toxicology, 315; 86-91.10.1016/j.tox.2013.11.01224321264
  24. Else, L. J., Jackson, A., Pils, R., Hill, A., Fahey, P., Lin, E., Amara, A., Siccardi, M., Watson, V., Tjia, J., Emery, S., Khoo, S., Back, D. J., and Boffito, M. (2012). Pharmacokinetics of lamivudine and lamivudinetriphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 study, Antimicrobial Agents and Chemotherapy, 56(3); 1427-1433.10.1128/AAC.05599-11
  25. Fang, J. L., McGarrity, L. J., and Beland, F. A. (2009). Interference of cell cycle progression by zidovudine and lamivudine in NIH 3T3 cells, Mutagenesis, 24(2); 133-141.10.1093/mutage/gen059
  26. Franchi, L. P., Pentiado, N. H. G. R., Silva, R. N., Guimarães, N. N., Jesuino, R. S. A., de Andrade, H. H. R., Lehman, M., and Cunha, K. S. (2009). Mutagenic and recombinagenic effects of lamivudine and stavudine antiretrovirals in somatic cells of Drosophila melanogaster, Food and Chemical Toxicology, 47; 578-582.10.1016/j.fct.2008.12.014
  27. Giri, S., Prasad, S.B., Giri, A., and Sharma, G.D. (2002). Genotoxic effects of malathion: an organophosphorus insecticide, using three mammalian bioassays in vivo, Mutation Research, 514; 223-231.10.1016/S1383-5718(01)00341-2
  28. Guimarães, N. N., Silva, C. J., de Andrade, H. H. R., Dihl, R. R., Lehmann, M., and Cunha, K. S. (2013). Comparative analysis of genetic toxicity of antiretroviral combinations in somatic cells of Drosophila melanogaster, Food and Chemical Toxicology, 53; 299-309.10.1016/j.fct.2012.12.00523261680
  29. Guimarães, N. N., Silva, C. J., Andrade, H. H. R., Dihl, R. R., Lehmann, M., and Cunha, K. S. (2013). Comparative analysis of genetic toxicity of antiretroviral combinations in somatic cells of Drosophila melanogaster, Food and Chemical Toxicology, 53; 299-309. doi: 10.1016/j.fct.2012.12.005.10.1016/j.fct.2012.12.005
  30. Hwang, Y. H., Park, H., and Ma, J. Y. (2013). In vitro and in vivo safety evaluation of Acer tegmentosum, Journal of Ethnopharmacology, 148(1); 99-105.10.1016/j.jep.2013.03.07423602732
  31. Kumar, N., and Singh, A. K. (2015). Trends of male factor infertility, an important cause of infertility: A review of literature. Journal of Human Reproductive Sciences, 8(4); 191-196.10.4103/0974-1208.170370469196926752853
  32. Kumari, G., and Singh, R. K. (2012). Highly active antiretroviral therapy for treatment of HIV/AIDS patients: current status and future prospects and the Indian scenario, HIV & AIDS Review, 11; 5-14.10.1016/j.hivar.2012.02.003
  33. Lewis, S. E., and Aitken, R. J. (2005). DNA damage to spermatozoa has impacts on fertilization and pregnancy, Cell and Tissue Research, 322; 33-41.10.1007/s00441-005-1097-515912407
  34. Lourenço, E. D., do Amaral, V. S., Lehmann, M., Dihl, R. R., Schmitt, V. M., Cunha, K. S., Reguly, M. L., and de Andrade, H. H. R. (2010). Micronuclei induced by reverse transcriptase inhibitors in mononucleated and binucleated cells as assessed by the cytokinesis-block micronucleus assay, Genetics and Molecular Biology, 33(4); 756-760.10.1590/S1415-47572010005000084
  35. Maartens, G., Celum, C., and Lewin, S. R. (2014). HIV infection: epidemiology, pathogenesis, treatment, and prevention, The Lancet, 384(9939); 258-271.10.1016/S0140-6736(14)60164-1
  36. Magdolenova, Z., Collins, A., Kumar, A., Dhawan, A., and Stone, V. (2014). Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles, Nanotoxicology, 8; 233-278.
  37. Morris, G. W., Iams, T. A., Slepchenko, K. G., and McKee, E. E. (2009). Origin of pyrimidine deoxynucleotide pools in perfused rat heart: implications for 30-azido-30-deoxythymidine-dependent cardiotoxicity, Biochemistry Journal, 422; 513–520.10.1042/BJ20082427
  38. Muller, J., Decordier, I., Hoet, P., Lombaert, N., and Thomassen, L. (2008). Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells, Carcinogenesis, 29; 427-433.10.1093/carcin/bgm243
  39. Ng, H. H., Stock, H., Rausch, L., Bunin, D., Wang, A., Brill, S., Gow, J., and Mirsalis, J. C. (2015). Tenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in mice, International Journal of Toxicology, 34(1); 4-10.10.1177/1091581814565669
  40. Ortblad, K. F., Lozano, R., and Murray, C. J. (2013). The burden of HIV: insights from the global burden of disease study 2010, AIDS, 27(13); 2003-2017.10.1097/QAD.0b013e328362ba67
  41. Oyeyemi, I. T., Yekeen, O. M., Odusina, P. O., Ologun, T. M., Ogbaide, O. M., Olaleye, O. I., and Bakare, A. A. (2015). Genotoxicity and antigenotoxicity study of aqueous and hydro-methanol extracts of Spondias mombin L., Nymphaea lotus L. and Luffa cylindrical L. using animal bioassays, Interdisciplinary Toxicology, 8(4); 184-192.
  42. Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., and Holmberg S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators, New England Journal of Medicine, 338(13); 853-860.10.1056/NEJM199803263381301
  43. Rasgele, P. G. (2014). Abnormal sperm morphology in mouse germ cells after short-term exposures to acetamiprid, probineb, and their mixture, Archives of Industrial Hygiene and toxicology, 65; 47-56.10.2478/10004-1254-65-2014-2408
  44. Rashid, A., Asmatullah, A., Zara, N., and Ara, C. (2012). Testicular toxicity induced by deltamethrin in albino mice, Pakistan Journal of Zoology, 44 (5); 1349-1353.
  45. Schmid, W. (1975). The Micronucleus test, Mutation Research, 31; 9-15.10.1016/0165-1161(75)90058-8
  46. The Joint United Nations Programme on HIV/AIDS (UNAIDS). (2017). Fact sheet July 2017. Retrieved January 20, 2018 from http://www.unaids.org/en/resources/fact-sheet.
  47. Tozzi, V. (2010). Pharmacogenetics of antiretrovirals, Antiviral Research, 85; 190-200.10.1016/j.antiviral.2009.09.00119744523
  48. Turner, P. V., Brabb, T., Pekow, C., and Vasbinder, C. A. (2011). Administration of substances to laboratory animals. Routes of administration and factors to consider, Journal of the American Association for Laboratory Animal Science, 50(5); 600-613.
  49. Utulu, S., and Bakare, A. A. (2010). DNA damage induced in the germ and bone marrow cells of mice by caffeine, West Africa Journal of Pharmacology and Drug Research, 5(8); 536 – 541.10.3923/rjbsci.2010.536.541
  50. Vernazza, P., Wang, C., Pozniak, A., Weil, E., Pulik, P., and Cooper, D. (2011). Efficacy and safety of lersivirine (UK-453,061) vs. efavirenz in antiretroviral treatment-naive HIV-1-infected patients: week 48 primary analysis results from an ongoing, multicentre, randomised, double-blind, phase IIb trial (study A5271015). 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 2011 Jul 1720; Rome, Italy. Abstract TUAB0101.
  51. Vidal, J. D., and Whitney, K. M. (2014). Morphologic manifestations of testicular and epididymal toxicity, Spermatogenesis, 2014 May-Aug; 4(2); e979099 (doi: 10.4161/21565562.2014.979099).
  52. Vivanti, A., Soheili, T. S., Cuccuini, W., Luce, S., Mandelbrot, L., Lechendec, J., Cordier, A. G., Azria, E., Soulier, J., Cavazzana, M., Blanche, S., and André-Schmutz, I. (2015). Comparing genotoxic signatures in cord blood cells from neonates exposed in utero to zidovudine or tenofovir, AIDS, 29; 1319-1324.10.1097/QAD.0000000000000564
  53. World Health Organisation (WHO). (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.
  54. Wutzler, P., and Thust, R. (2001). Genetic risks of antiviral nucleoside analogues – a survey, Antiviral Research, 49; 55-74.10.1016/S0166-3542(00)00139-X
  55. Wyrobek, A. J., and Bruce W. R. (1975). Chemical induction of sperm abnormalities in mice, proceeding of the National Academy of Science, 72; 4425-4429.10.1073/pnas.72.11.44253887341060122
  56. Wyrobek, A. J., Gordon, L. A., Burkhart, J. G., Francis, M. W., Kapp (Jr.), R. W., Letz, G., Malling, H. G., Topham, J. C., and Whorton, M. D. (1983). An evaluation of the mouse sperm morphology test and other sperm tests in non-human mammals. A report of the United States Environmental Protection Agency Gene – Tox Programme, Mutation Research, 115; 1-72.
  57. Zini, A. (2011). Are sperm chromatin and DNA defects relevant in the clinic? System Biology and Reproductive Medicine, 57; 78-85.10.3109/19396368.2010.51570421208147
Language: English
Page range: 1 - 10
Submitted on: Oct 4, 2019
|
Accepted on: Dec 23, 2019
|
Published on: Jul 6, 2020
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2020 Adekunle A. Bakare, Kehinde M. Akinseye, Bayonle A. Aminu, Francis C. Ofoegbu, Saheed O. Anifowose, Stork Abruda, Opeoluwa M. Fadoju, Olusegun I. Ogunsuyi, Ifeoluwa T. Oyeyemi, Okunola A. Alabi, Olusola M. Adetona, Chibuisi G. Alimba, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.